Aesica appoints VP, Business Development and Business Development Director for Finished Dose

To drive service in Europe and achieve further growth

CDMO Aesica has appointed two people to senior business development positions.

Detlef Behrens has taken the role of Vice President, Business Development, Finished Dose, while Sven Wrabletz has joined the company as Business Development Director, Finished Dose.

Behrens has overall responsibility for business development and for finished dose services, covering formulation development, bulk manufacturing and packaging with a full international remit across the Group.

Wrabletz is also responsible for finished dose development, manufacturing and packaging but with a geographic remit covering Northern Germany, Benelux and Eastern Europe.

Both positions are based in Germany. Behrens reports directly to Ian Muir, Managing Director, Finished Dose. Prior to working for Aesica, he held senior business development roles at Piramal and NextPharma.

Wrabletz reports to Behrens and joined Aesica from packaging specialist Clondalkin.

You may also like